Core Viewpoint - Emrosi™ has demonstrated efficacy in treating moderate-to-severe papulopustular rosacea, independent of body weight differences, supporting its FDA approval in November 2024 [1][6][8] Group 1: Clinical Trial Results - Data from two Phase 3 trials (MVOR-1 and MVOR-2) showed that Emrosi can be prescribed without regard to body weight, reducing potential dosing errors [2][5] - In MVOR-1, 75.5% of subjects with body weight ≤ median achieved IGA treatment success with Emrosi compared to 51.0% with doxycycline and 28.2% with placebo [4] - In MVOR-2, 65.0% of subjects with body weight > median achieved IGA treatment success with Emrosi compared to 33.9% with doxycycline and 22.6% with placebo [4] Group 2: Efficacy and Safety - Emrosi showed superior efficacy on both co-primary endpoints compared to placebo and doxycycline, with no significant differences in adverse events reported [5][6] - The most common adverse reaction was dyspepsia, occurring in ≥1% of subjects treated with Emrosi [9] Group 3: Company Overview - Journey Medical Corporation focuses on marketing FDA-approved prescription products for dermatological conditions and currently markets eight such products [11] - The company is based in Scottsdale, Arizona, and was founded by Fortress Biotech, Inc. [11]

Core Viewpoint - Saratoga Investment Corp. will report its financial results for the fiscal quarter ended May 31, 2025, on July 8, 2025, with a conference call scheduled for July 9, 2025, to discuss these results [1][2]. Company Overview - Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses [3]. - The company primarily invests in senior and unitranche leveraged loans and mezzanine debt, with a lesser focus on equity, to finance ownership changes, strategic acquisitions, recapitalizations, and growth initiatives [3]. - The objective of Saratoga Investment is to generate attractive risk-adjusted returns through current income and long-term capital appreciation from its debt and equity investments [3]. - The company is regulated as a business development company under the Investment Company Act of 1940 and is externally managed by Saratoga Investment Advisors, LLC, which focuses on credit-driven strategies [3]. - Saratoga Investment Corp. owns two active SBIC-licensed subsidiaries and manages a $550 million collateralized loan obligation (CLO) fund, along with co-managing a joint venture fund that owns a $400 million CLO [3]. - The company holds 52% of the Class F and 100% of the subordinated notes of the CLO, as well as 87.5% of both the unsecured loans and membership interests of the JV and 87.5% of the Class E notes of the JV CLO [3]. - The diverse funding sources and a permanent capital base enable Saratoga Investment to offer a wide range of financing solutions [3].

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Pfizer (NYSE: PFE ) is arguably the biggest victim of the radical new healthcare policies being brought about by the Trump administration, and in my view, this means that its dividend - currently yielding >7% perTh ...

Company Overview - Gaia, Inc. is a conscious media and community company that operates a global video streaming service, producing and curating content across four primary channels: Seeking Truth, Transformation, Alternative Healing, and Yoga [3] - The service is available in four languages (English, Spanish, French, and German) and serves members in 185 countries [3] - Gaia's library includes over 10,000 titles, with more than 88% being exclusive to the platform, and approximately 75% of viewership is generated by content produced or owned by Gaia [3] Upcoming Events - Gaia's management will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24 and 25, 2025 [1] - CEO James Calhoun and CFO Ned Preston will deliver a company presentation on June 24, followed by one-on-one meetings with investors on June 25 [1][2] Investor Engagement - The iAccess Alpha conferences feature companies recommended by investors, including webcast presentations on Day 1 and one-on-one meetings on Day 2 [2] - Interested parties can register and schedule meetings with Gaia through the conference website [2]

VANCOUVER, BC, June 20, 2025 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today announced the commencement of separate offers (the "Offers") to purchase for cash up to C$600,000,000 (the "Maximum Purchase Amount") in aggregate purchase price, excluding accrued and unpaid interest, of its outstanding senior notes of the eight series listed in the table below (collectively, the "Notes"), which Maximum Purchase Amount may be increased, decreased or waived by the Company in its sole discretion. E ...

SCOTTSDALE, AZ, June 20, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today provided an update on the expected timing for the closing of its previously announced acquisition of Yerbaé Brands Corp. (TSX-V: YERB.U) (“Yerbaé”). Following the approval of the acquisition by a majority of its stockholders on June 12, 2025, the companies have been working to complete the final administrative steps for the transaction. While the closing was anticipated this week, the pr ...

Vancouver, BC, June 20, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) announces that it has closed a non-brokered private placement financing for total gross proceeds of CAD $2,250,000 (the “Private Placement”). The Private Placement attracted participation from two strategic institutional investors. Trident has allotted and issued 3,000,000 units (the “Units”) at a price of CAD $0.75 per Unit. Each Unit is comprised of one flow-through common sha ...

VANCOUVER, B.C., June 20, 2025 /PRNewswire/ - TELUS Corporation (the "Company") announced today the commencement of separate offers (the "Offers") to purchase for cash any and all of the two series of outstanding notes of the series listed in the table below (collectively, the "Notes"), up to a maximum of US$750,000,000 aggregate principal amount of Notes. Subject to the Maximum Purchase Condition (as defined below) and the Financing Condition (as defined below), the series of Notes that are purchased in th ...

KUALA LUMPUR, Malaysia, June 20, 2025 (GLOBE NEWSWIRE) -- Founder Group Limited (NASDAQ: FGL) (“Founder Group” or the “Company”), a leading engineering, procurement, construction, and commissioning (EPCC) solutions provider for solar photovoltaic systems in Malaysia, assures investors that the Company will not be impacted by a U.S. Senate panel’s proposed wind down of solar power tax credits by 2028. “Founder Group operates primarily in Malaysia and doesn’t have operations in the U.S. Therefore, the Compan ...

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to announce that, due to existing and strategic investor demand, it has increased the size of its non-brokered listed issuer financing exemption (“LIFE”) private placement (the "LIFE Offering"), as previously announced on June 19, 2025, to 25,000,000 units of the C ...